Acute hepatitis B with delta-agent
ICD-10 B17.0 is a billable code used to indicate a diagnosis of acute hepatitis b with delta-agent.
Acute hepatitis B with delta-agent is a viral infection of the liver caused by the hepatitis B virus (HBV) in conjunction with the hepatitis D virus (HDV), which is a defective virus that requires HBV for its replication. This condition typically presents with symptoms such as jaundice, fatigue, abdominal pain, and elevated liver enzymes. The delta agent can exacerbate the severity of hepatitis B, leading to a higher risk of acute liver failure and chronic liver disease. Transmission occurs primarily through blood and bodily fluids, including sexual contact and sharing of needles. Acute hepatitis B with delta-agent can lead to serious complications, including fulminant hepatitis, cirrhosis, and hepatocellular carcinoma. Management involves supportive care, monitoring liver function, and in some cases, antiviral therapy. Understanding the interplay between HBV and HDV is crucial for effective treatment and management of the disease.
Detailed history of exposure, lab results confirming HBV and HDV co-infection.
Patients presenting with jaundice and elevated liver enzymes after known exposure.
Ensure documentation reflects the acute nature and co-infection status.
Liver function tests, imaging studies, and treatment plans.
Management of patients with acute liver failure due to co-infection.
Focus on liver biopsy results and long-term management strategies.
Used to confirm the presence of hepatitis B virus.
Document the reason for testing and results.
Infectious disease specialists may require additional serological tests.
The delta-agent (HDV) can worsen the severity of hepatitis B infection, leading to increased risk of liver damage and complications.
